Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/13963
Title: Similar proteomic profiles of human mesenchymal stromal cells from different donors
Authors: Silva, Carolina Lazzarotto
Binato, Renata
Rocher, Ba´rbara Du
Costa, Júlia Assunção Costa e
Pizzatti, Luciana
Bouzas, Luis Fernando da Silva
Abdelhay, Eliana Saul Furquim Werneck
Keywords: Bone Marrow Transplantation
Transplante de Medula Óssea
Imunoterapia Adotiva
Immunotherapy Adoptive
Células-Tronco Mesenquimais
Mesenchymal Stem Cells
Proteoma
Proteome
Células Estromais
Stromal Cells
Proteômica
Proteomics
Estudo de Avaliação
Evaluation Study
third-party
terceiros
Issue Date: 2009
Abstract: Bone marrow (BM) stromal cells, also referred to as mesenchymal stromal cells (MSC), can be expanded ex vivo and are able to differentiate along multiple lineages, including chondrocytes, osteoblasts and adipocytes. MSC are known to secrete a number of cytokines and regulatory molecules implicated in different aspects of hematopoiesis, and seem to modulate the immune system. MSC appear to be promising candidates for cellular therapy associated with BM transplantation (BMT). Methods We compared protein expression profiles of MSC cultures derived from different BM donors using two-dimensional (2-D) gel electrophoresis and matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) tandem mass spectrometry (MS/MS), and compared mixed lymphocyte reaction (MLR) assays in the absence and presence of third-party human (h) MSC derived from different donors during the same culture passage. Results In a window of observation (pH 4 7, molecular weight 10 220 kDa), about 172 protein spots were obtained in each 2-D gel, corresponding to 84 distinct proteins. A comparative analysis demonstrated a very similar proteomic profile of cells of the first passage derived from different donors, suggesting that these cells have the same expression pattern. Additionally, cells derived from different donors were equally able to inhibit lymphocyte proliferation. Conclusions These results encourage the use of third-party MSC in cellular therapies, as cells derived from different individuals seem to have the same proteomic pattern and exhibit functionally similar properties.
URI: https://ninho.inca.gov.br/jspui/handle/123456789/13963
ISSN: 1477-2566
Appears in Collections:Hospital do Câncer I (HCI)



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.